Xspray Pharma AB (publ) (XSPRAY.ST)

SEK 26.5

(1.73%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - 277 Thousand
Cost of Revenue 9.19 Million 9.53 Million 8.87 Million 1.41 Million 4.8 Million -
Gross Profit -9.19 Million -9.53 Million -8.87 Million -1.41 Million -4.8 Million 277 Thousand
Operating Expenses 181.73 Million 131.38 Million 96.95 Million 53.64 Million 45.75 Million 22.91 Million
Selling, General and Administrative Expenses 169.56 Million 109.6 Million 58.38 Million 47.1 Million 42.32 Million 16.96 Million
Research and Development Expenses 33.58 Million 22.21 Million 38.56 Million 6.54 Million 3.42 Million 5.53 Million
Other Expenses - -438 Thousand - -5000.00 - 414 Thousand
Cost and Expenses 181.73 Million 131.38 Million 96.95 Million 53.64 Million 45.75 Million 22.91 Million
Operating Income -180.76 Million -133.07 Million -97.95 Million -53.45 Million -45.7 Million -23.21 Million
Interest Expense 675 Thousand 12 Thousand 4000.00 6000.00 69 Thousand 31 Thousand
Income Tax Expense -17 Thousand -1.4 Million 4000.00 -107 Thousand 66 Thousand -427 Thousand
Earnings before Tax -179.68 Million -131.67 Million -96.69 Million -52.41 Million -45.77 Million -23.09 Million
Net Income -179.66 Million -130.26 Million -96.7 Million -52.3 Million -45.83 Million -23.09 Million
Earnings Per Share Basic -6.76 -6.13 -4.98 -3.01 -2.99 -1.68
Earnings Per Share Diluted -6.76 -6.13 -4.98 -3.01 -2.99 -1.63
Weighted Average Shares Outstanding 26.57 Million 21.26 Million 19.41 Million 17.36 Million 15.35 Million 13.71 Million
Weighted Average Shares Outstanding (Diluted) 26.59 Million 21.26 Million 19.41 Million 17.36 Million 15.35 Million 14.18 Million
Gross Margin - - - - - 1.00
EBIT Margin - - - - - -68.20
Profit Margin - - - - - -83.39
EBITDA -169.81 Million -122.12 Million -87.82 Million -50.99 Million -40.9 Million -19.07 Million
Earnings Before Tax Margin - - - - - -83.82

Income Statement Charts